THE FIRST VIENAM CONFERENCE ON LIVER DISEASES 2022
On the morning of July 28, 2022, the first Vietnam International Conference on Liver Diseases was held with the main theme of “Viral Hepatitis B-C-D and Liver Cancer in Vietnam: Current Status and Future Directions”. The conference attracted more than 100 experts, doctors, researchers in this field to participate and contribute important ideas.
Assoc.Prof.Dr. Le Van Canh – Vice President of International University – delivered the opening speech on the morning of July 28, 2022.
Liver cancer caused by viral hepatitis B (HBV), viral hepatitis C (HCV), and viral hepatitis D (HDV) have become the challenging and urgent issues in Vietnam. Since 2018, liver cancer has surpassed lung cancer and become the most common cause of cancer death in Vietnam. More than 25,000 cases of liver cancer are reported each year in southern Vietnam , making Vietnam the fourth highest country in the world contracting liver cancer with age-adjusted incidence rates being 23.2 cases per 100,000 persons. Meanwhile, the ratio in the United States is 6.7/100,000. It is predicted that liver cancer associated with viral hepatitis will continue to increase over the next two decades unless an effective national intervention program takes place.
Second-degree Specialist – Nguyen Dinh Song Huy – Director of People’s Center of Liver Tumor Department, Cho Ray Hospital – reported at the Workshop.
To help address gaps and reverse the trends of liver cancer in Viet Nam, the Center of Excellence for Liver Diseases in Vietnam (Johns Hopkins University School of Medicine – COE / JHU), Research Center for Infectious Diseases, Vietnam National University Ho Chi Minh City (RCID, VNU-HCM) and School of Medicine, Vietnam National University Ho Chi Minh City (SOM, VNU-HCM) jointly organized the inaugural 2022 scientific conference, “HBV, HCV, HDV, and Liver Cancer in Viet Nam: Current Status and Future Directions”. The workshop was organized with the hope to promote initiatives to eliminate viral hepatitis, the primary cause for liver cancer in Vietnam.
Assoc.Prof.Dr. Nguyen Phuong Thao – Director of the Research Center for Infectious Diseases (VNU-HCM) – shared: “We hope the Workshop can provide a platform to strengthen cooperation between clinicians and researchers in the fields of viral hepatitis and liver cancer, and utilize evidence-based research data to design intervention programs that address the growing burden of liver cancer in Vietnam”.
The conference was organized in two formats, offline and online.